Krikun Graciela, Schatz Frederick, Taylor Hugh, Lockwood Charles J
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, School of Medicine. 333 Cedar St., P.O. Box 208063, New Haven, CT, 06520-8063, USA.
Ann N Y Acad Sci. 2008 Apr;1127:101-5. doi: 10.1196/annals.1434.008.
Tissue factor (TF), is a cellular receptor that binds the ligand factor VII/VIIa to initiate the blood coagulation cascade. In addition to its role as the initiator of the hemostatic cascade, TF is known to be involved in angiogenesis via an interaction with factor VIIa and protease-activated receptor-2 (PAR-2). In this article we review previous studies from our laboratory demonstrating that the pattern and level of TF expression is altered in multiple cell types derived from eutopic and ectopic endometrium from women with endometriosis compared with normal endometrium. We posit that the inflammatory environment that occurs in ectopic and eutopic endometrium from patients with disease results in high TF expression that in turn, signals via PAR-2 to further produce inflammatory cytokine or chemokine production and macrophage recruitment. Thus, our studies suggest that TF might be an ideal target for therapeutic intervention in endometriosis.
组织因子(TF)是一种细胞受体,它与配体因子VII/VIIa结合以启动血液凝固级联反应。除了作为止血级联反应的启动因子外,已知TF通过与因子VIIa和蛋白酶激活受体-2(PAR-2)相互作用参与血管生成。在本文中,我们回顾了我们实验室以前的研究,这些研究表明,与正常子宫内膜相比,子宫内膜异位症患者在位和异位子宫内膜来源的多种细胞类型中TF的表达模式和水平发生了改变。我们认为,疾病患者异位和在位子宫内膜中出现的炎症环境导致TF高表达,进而通过PAR-2发出信号,进一步产生炎性细胞因子或趋化因子,并募集巨噬细胞。因此,我们的研究表明,TF可能是子宫内膜异位症治疗干预的理想靶点。